2018 International Congress Archives - Page 53 of 177

1:45pm-3:15pm: The impact of a wearable device on Parkinson’s disease motor symptom management in patients starting rotigotine transdermal patch

S. Isaacson, B. Boroojerdi, K. Klos, S. Carson, M. Markowitz, D. Heldman, M. Phillips, D. Terricabras, F. Woltering, D. Truong (Boca Raton, FL, USA)

Technology · Hall 3FG

1:45pm-3:15pm: The impact of APOε4 polymorphisms and mutations in the GBA gene on the clinical features of Dementia with Lewy Bodies among Ashkenazi Jews

T. Shiner, A. Mirelman, Y. Rozenblum, G. Kave', M. Gana Weisz, A. Bar-Shira, A. Thaler, T. Gurevich, A. Orr-Urtreger, N. Gilad, N. Bregman (Tel Aviv, Israel)

Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus) · Hall 3FG

1:45pm-3:15pm: The impact of bilingualism in brain structure and function in early and mild Huntington’s disease

S. Martinez-Horta, A. Moreu, F. Sampedro, J. Perez-Perez, A. Horta-Barba, J. Pagonabarraga, J. Marin-Lahoz, H. Bejr-Kasem, J. Kulisevsky (Barcelona, Spain)

Huntington's Disease · Hall 3FG

1:45pm-3:15pm: The Impact of short in-patient rehabilitation courses for people with Parkinson´s disease

S. Kinos, K. Martikainen, T. Vahlberg, R. Marttila (Turku, Finland)

Other · Hall 3FG

1:45pm-3:15pm: The independence in daily living activities is the best predictor for quality of life in people with Parkinson’s disease

C. Dionizio, E. Okamoto, C. Miranda, M. d'Alencar, M.E. Piemonte (São Paulo, Brazil)

Quality Of Life/Caregiver Burden in Movement Disorders · Hall 3FG

1:45pm-3:15pm: The international MDSGene initiative: Systematically exploring genotype-phenotype correlations of hereditary movement disorders

S. Petkovic, S. Schaake, J. Huang, H. Madoev, A. Rasheed, C. Lill, K. Lohmann, C. Klein, C. Marras (Lübeck, Germany)

Technology · Hall 3FG

1:45pm-3:15pm: The Levodopa Response Trial and the Parkinson Disease Digital Biomarker Challenge: Monitoring symptoms of Parkinson’s disease in the lab and home using wearable sensors

J. Daneault, G. Vergara-Diaz, G. Costante, E. Fabara, G. Ferreira-Carvalho, F. Golabchi, F. Parisi, S. Sapienza, Y. Chae, P. Snyder, P. Aubin, P. Banda, D. Brunner, R. Dorsey, L. Mangravite, W. Marks, E. Neto, U. Rubin, E. Soderberg, D. Daeschler, S. Moore, S. Sieberts, L. Omberg, P. Bonato, The Parkinson's Disease Digital Biomarker DREAM Challenge Consortium (Newark, NJ, USA)

Technology · Hall 3FG

1:45pm-3:15pm: The phenotype of ATP1A3+ Rapid-Onset Dystonia-Parkinsonism (RDP) is broader than previously defined

I. Haq, B. Snively, C. Suerken, J. Cook, C. Miller, K. Sweadner, L. Ozelius, C. Whitlow, A. Brashear (Winston Salem, NC, USA)

Dystonia · Hall 3FG

1:45pm-3:15pm: The Predictor Factors on Quality of Life in Patients with Parkinson’s Disease

AD. Wijono, RT. Pinzon (Yogyakarta, Indonesia)

Quality Of Life/Caregiver Burden in Movement Disorders · Hall 3FG

1:45pm-3:15pm: The prevalence and associated features of REM sleep without atonia

F. Dijkstra, M. Viaene, I. de Volder, D. Crosiers, P. Cras (Antwerp, Belgium)

Restless Legs Syndrome and Other Sleep Disorders · Hall 3FG